The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at $367m (£272m) over five years over the United States' insistence on confidential data.
This rejection was revealed following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
An official spokesman later clarified that the US was demanding access to biological samples for research and commercial gain but was not willing to guarantee the benefits from any future treatments.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more negotiations to secure a agreement agreeable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Implications
This rejection follows a similar case in neighbouring Kenya, where a court suspended a related health funding agreement after concerns were raised about the security of citizens' medical information.
After resuming office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government agreements to boost openness and accountability.
According to statements, Sixteen nations in Africa have so far agreed to these new health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," his statement read.
"In essence, our nation would supply the basic resources for scientific discovery without any certainty that the end products would be accessible to our population should a new health crisis arise."
Sovereignty and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining structures previously set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.
"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further discussions with our American counterparts on how subsequent co-operation could be designed in a manner that respects the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that negotiations should continue given that much of the country's Aids initiatives depended on international support.
"Where technical issues exist, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," the group commented.
This impasse highlights the complex challenges between receiving much-needed foreign assistance and protecting local interests in an increasingly data-driven world.